Dr. Nazmi Baycin, DHA-licensed board-certified plastic surgeon in Dubai
Ask a surgeon whether liposuction is permanent and you will hear yes. Ask what happens if you gain weight afterward and the answer becomes vague. I have performed body contouring in Dubai for twenty-five years, and I have come to believe the vagueness is the interesting part. Your body keeps a running total of its own fat mass. It defends that total. Liposuction removes fat cells from a place you chose, and your physiology responds to a loss it never agreed to. Understanding what it does next is the difference between a result that pleases you for a decade and one that puzzles you within a year.

Key takeaways: what your body does after the fat is gone

  • Around 10% of your fat cells are replaced annually, yet the total number stays constant. The count is a defended set point.
  • In a randomized trial, the treated thigh stayed reduced at one year — but fat reaccumulated in the untreated abdomen.
  • Fat cells cannot migrate. What returns is new storage in cells that were never removed.
  • Removing roughly 10 kg of subcutaneous fat changed insulin sensitivity not at all in muscle, liver, or adipose tissue.
  • Liposuction never reaches visceral fat — the depot that actually drives metabolic risk.
  • The evidence on large-volume cases is genuinely conflicting, and I will not pretend it is settled.

A note on scope: this article is about the biology that follows the operation. How liposuction is performed — the tumescent technique, the cannulas, the recovery, the cost — belongs to my page on liposuction in Dubai. What follows assumes you already understand the procedure and want to know what your body will make of it.

The set point almost nobody explains

The familiar account goes like this. Fat cells stop multiplying in adolescence. Adults gain weight by filling existing cells, not by making new ones. Remove the cells and they never come back. That account is nearly right, and its error is instructive. Researchers dated human fat cells using carbon-14 absorbed from Cold War nuclear tests, and found something no one expected. Roughly one in ten of your adipocytes is replaced every year. They die. New ones are generated. The turnover is brisk at every adult age and at every body mass index. And yet the total number holds steady. It holds steady in lean people and obese people alike, and it holds steady even after substantial weight loss.

So fat cells are not permanent. The *number* of them is what your body guards. This distinction matters enormously, because it means adipocyte count is not a passive inventory left over from childhood. It is an actively regulated quantity — a set point, maintained by a system that notices when the total falls. Liposuction makes the total fall. Deliberately, and by design.

Diagram titled liposuction removes fat cells but it does not remove the set point, explaining that the body keeps a running total of its own fat mass and defends that total after surgery. A section describes two things the operation touches and one it never reaches. Subcutaneous fat cells are removed: adipocytes suctioned from the treated zone are gone and the count in that area is permanently lower, which is the contour and it is real. Visceral fat is untouched: the fat around the organs cannot be reached by a cannula, nor can fat inside muscle or liver, and this is the metabolism, which is not addressed. The set point is defended: total adipocyte number is regulated as a set point, so removing cells makes the body work to restore the total, and this is what almost nobody explains. A panel notes that roughly ten percent of your fat cells are replaced every year yet the total number holds constant through adulthood, meaning adipocytes are not permanent but the number of them is what the body guards. A section on what a randomized trial found one year after liposuction contrasts two regions. The treated thigh stayed reduced: twelve months later the thigh region remained measurably smaller than it had been, and the fat did not come back to the place it was taken from. The untreated abdomen reaccumulated: over the same year adipose tissue returned in the abdominal region which had never been operated on, so body fat was restored rather than migrated. A panel explains that fat does not travel and fat cells have no capacity for movement, that what returns is new storage laid down in the cells that remain wherever the body still has them in abundance, that the thigh keeps its result because its cells were removed, and that the abdomen absorbs the surplus because its cells were never touched. A section headed ten kilograms of fat removed with insulin sensitivity unchanged gives four panels. Muscle showed no change, as glucose disposal was measured before and after and did not improve with the fat removed. Liver showed no change, as suppression of glucose production was equally unmoved and intrahepatic fat was never removed. Inflammation showed no change, as C-reactive protein, interleukin-6, TNF-alpha and adiponectin were all statistically flat. The reason given is the wrong depot: visceral fat, fat cell size, and fat inside muscle and liver were all left exactly as they were. A caution panel titled where the evidence genuinely disagrees explains that a systematic review of large-volume liposuction reports leptin falling, adiponectin rising, and insulin sensitivity improving in six of ten studies, that its authors call the data conflicting, that removing more fat from heavier patients may do more than removing less from lighter ones, and that liposuction is not sold as metabolic medicine because no honest reading of this literature would allow it. A closing section on what this means for the plan states that the contour created is durable, the weight carried remains the patient's to govern, that gaining weight means gaining in the depots not treated so the proportions built will read differently, and that this is not a complication but the arithmetic of a defended set point. The final line reads liposuction edits where fat sits, it does not edit how much your body wants.

Liposuction permanently removes adipocytes from a treated zone, but the body defends its total fat mass and never surrenders the visceral depot — by Dr. Nazmi Baycin, Dubai.

What happened when someone actually tested it

For years, the question of whether fat returns after liposuction was answered with assertion rather than evidence. Then a research team ran the trial properly: nonobese women, randomized either to small-volume liposuction or to no surgery, tracked for a full year with imaging. The result deserves to be better known than it is. At twelve months, the treated thigh region remained measurably reduced. The fat did not return to where it had been taken from. But adipose tissue had reaccumulated in the abdomen — a region that was never operated on. Body fat was restored. It simply came back somewhere else.

Why this is not fat “moving”

I want to be exact here, because the internet is not. Fat does not travel. An adipocyte is a cell embedded in connective tissue with its own blood supply. It has no mechanism of locomotion whatsoever. Nothing migrates from your thigh to your abdomen, and any surgeon who describes it that way is describing something that cannot occur. What happens is arithmetic. Suppose you enter a sustained caloric surplus. Your body must store that surplus somewhere, and it stores it in the adipocytes it has. The thigh now has fewer cells to fill, so it fills less. The abdomen has its full complement, so it absorbs the difference. The thigh keeps its result *because* its cells were removed. The abdomen expands *because* its cells were never touched. Two consequences of a single operation, pointing in opposite directions.

The claim What patients are told What the evidence shows What I tell you
Fat cells Never regenerate ~10% replaced yearly The count is defended
Weight regain Spreads evenly Favors untreated depots Proportions will shift
Fat redistribution Fat migrates Fat cannot move New storage, old cells
Metabolic benefit Improves health Insulin action unchanged Contour, not cure
Visceral fat Rarely mentioned Never removed Diet and exercise only

Ten kilograms of fat, and a metabolism that did not notice

Here is the finding that shaped how I consult. Investigators removed roughly ten kilograms of subcutaneous abdominal fat from obese women and then measured, with the rigor of a metabolic laboratory, what had changed. The insulin sensitivity of muscle was unchanged. The insulin sensitivity of the liver was unchanged. The insulin sensitivity of adipose tissue itself was unchanged. C-reactive protein, interleukin-6, TNF-alpha, adiponectin — all statistically flat. Blood pressure, glucose, lipids: no significant effect. Ten kilograms of fat, gone, and the metabolism did not register the loss. The reason is anatomical, and once you see it you cannot unsee it. My cannula travels beneath the skin, above the muscle. It cannot reach visceral fat, the tissue packed around your organs. It does not alter the size of the fat cells that remain. It does not touch the fat deposited inside muscle fibers or within the liver. Those depots are what drive insulin resistance. Weight loss shrinks them. Surgery does not go near them. So liposuction removes the fat you can pinch, and leaves untouched the fat that is trying to hurt you. That sentence is the most useful thing I can tell a patient in Dubai who arrives hoping surgery will fix a metabolic problem.

Where the evidence genuinely disagrees

I would be misrepresenting the literature if I stopped there, and I have no appetite for that. A systematic review of large-volume liposuction — defined as more than 3.5 liters of aspirate — reports a different picture. Leptin fell significantly in four studies. TNF-alpha fell in two. Adiponectin rose in two. Of ten studies assessing insulin sensitivity, six found improvement. The authors describe their own data as conflicting, and conclude that large-volume liposuction “may” affect cardiovascular risk and insulin resistance in positive ways. They call for prospective studies.

How do I reconcile this with the trial above? Honestly, and incompletely. Volume differs. The patients differ — heavier people with more inflammatory adipose tissue may respond where lighter people do not. Follow-up windows differ, and postoperative inflammation can mask an effect that emerges later. What I will not do is select the study that flatters the procedure.

If a surgeon quotes you the encouraging review without mentioning the controlled trial, you are being sold something. If I quoted you only the controlled trial, I would be doing the same thing in the opposite direction. My position: liposuction is a contouring operation with a possible, unproven, volume-dependent metabolic dividend. I plan for the contour. Anything else is a welcome surprise.

How this shapes the operation I actually perform

Biology of this kind is not an abstraction. It changes where I put the cannula.

  • I never treat a single zone in isolation. If the abdomen is aggressively reduced while the flanks and hips are left at full cell density, future weight gain will land in the flanks and read as a deformity. The surrounding regions must be brought into relationship.
  • I preserve a deliberate superficial layer. Deep fat is removed; a stratum beneath the skin is retained. This protects the skin from contour irregularity and preserves the smooth transitions that make a result look unoperated.
  • I plan for the body you may have, not only the one before me. A silhouette that only works at your current weight is a poorly designed silhouette.
  • I decline patients who want surgery instead of weight loss. Not from severity. From the evidence above.

That retained superficial layer is doing structural work rather than metabolic work, and the architecture it belongs to — the fibrous septa and fascial scaffold that decide whether an abdominal contour lasts — is a separate question from how much fat the body wants to carry, and I treat it separately there.

This is also why I evaluate skin quality with as much care as fat volume. When the envelope will not retract over the reduced contour, I discuss J Plasma skin tightening in Dubai, which addresses laxity that removal alone cannot. And where fat is being reduced in one place to build volume in another, the biology of graft survival becomes the governing question — see my page on Brazilian butt lift in Dubai. Where the aim is muscular definition rather than volume reduction, the surgical logic changes again, and I have set that out in my article on the 4D concept in liposculpture.

Your half of the arrangement

I am responsible for the distribution of your fat cells. You remain responsible for the volume of what fills them. That division of labor is not a disclaimer. It follows directly from everything above. I can lower the cell count in a region permanently. I cannot lower your set point, alter your visceral fat, or change the genetics and hormones that decide how readily you store energy. So the maintenance that preserves a result is unglamorous:

  • Weight stability above all. Not thinness. Stability. A defended set point punishes oscillation more than it punishes weight itself.
  • Resistance training, because lean mass is the principal determinant of basal metabolic rate, and it is the one variable in this article you can genuinely increase.
  • Nutrition that avoids sustained surplus, since surplus must be stored, and it will be stored where your cells remain.

Patients sometimes hear this as a lecture. It is meant as the opposite. The operation works; that is why the arrangement is worth honoring. You may find the recovery science in my article on my advanced recovery protocol in Dubai useful in the first weeks, and where skin laxity dominates the picture rather than fat, the answer may instead lie in body contouring in Dubai.

Ask a better question

When a patient asks whether the fat comes back, I answer no — not where I removed it, and a randomized trial supports me. Then I tell her what she has not asked, because it is what will actually determine how she feels about her body in five years. Ask where the fat will go if you gain. Ask which depots were left untouched. Ask whether the surgeon has thought about your silhouette at a weight you do not currently hold. Ask, if he claims a metabolic benefit, which study he means and whether he has read the one that found none.

A surgeon who has thought carefully about a defended set point has thought carefully about everything else. That is the standard I hold as a board-certified plastic surgeon in Dubai, and it is a better question than asking whether fat cells grow back. Liposuction edits where fat sits. It does not edit how much your body wants. Work with that sentence, and the result will outlast the fashion that brought you to it.

FAQs about liposuction and fat metabolism in Dubai

  1. Do fat cells grow back after liposuction?

    Not in the area I treated, though the honest answer is more interesting than a simple no. Carbon dating of human adipocytes shows that around ten percent of your fat cells are replaced every year, at every adult age. Yet the total number stays constant. What your body regulates is the count, not the individual cells, and it defends that count as a set point. So the treated region keeps its reduced cell population. What the body restores, it restores elsewhere.

  2. Does fat move to other areas after liposuction?

    No. Fat cannot travel. An adipocyte is a cell anchored in connective tissue with its own blood supply, and it has no means of locomotion at all. What a randomized trial did find is that one year after liposuction the treated thigh stayed reduced, while adipose tissue reaccumulated in the untreated abdomen. Body fat was restored, not relocated. So if you gain weight, the surplus is stored in the cells that remain. The abdomen expands because its cells were never touched. It is arithmetic rather than migration.

  3. Does liposuction improve my metabolism or insulin resistance?

    On the best available evidence, no. Investigators removed around ten kilograms of subcutaneous abdominal fat from obese women and measured the result in a metabolic laboratory. Insulin sensitivity in muscle, liver and adipose tissue was unchanged. C-reactive protein, interleukin-6, TNF-alpha and adiponectin were all flat. So were blood pressure, glucose and lipids. So the reason is anatomical. My cannula travels beneath the skin and above the muscle. It never reaches visceral fat, and visceral fat is what drives insulin resistance.

  4. Is liposuction permanent?

    The contour is, and I say that with a randomized trial behind me rather than a slogan. Twelve months after surgery, the treated thigh region remained measurably smaller than it had been. The adipocytes I remove do not return to that region. That is the source of the permanence, and it is genuine. So what is not permanent is your weight, and that was never mine to remove. The shape endures. The volume filling it remains yours to govern.

  5. What is visceral fat and why can liposuction not remove it?

    Visceral fat is the adipose tissue packed around your internal organs, deep to the abdominal wall. Subcutaneous fat, which is what I remove, sits between the skin and the muscle. A cannula cannot cross the muscular wall, and it should never try. Nor does liposuction alter the fat deposited inside muscle fibers or within the liver. So those are precisely the depots that drive metabolic risk, and they respond to weight loss rather than to surgery. Liposuction removes the fat you can pinch.

  6. What happens if I gain weight after liposuction in Dubai?

    You will gain, and you will gain preferentially in the regions I did not treat. The treated zone has fewer cells available to fill, so it fills proportionally less. This is not a complication and it is not a failure of technique. It is the predictable arithmetic of storing a surplus in an altered distribution of fat cells. So this is why I never treat one zone in isolation. If I reduce an abdomen aggressively and leave the flanks at full density, future weight gain will land in the flanks and read as a deformity.

  7. Some studies say liposuction improves cholesterol and insulin. Are they wrong?

    Not wrong, and I will not hide them from you. A systematic review of large-volume liposuction found leptin falling significantly in four studies, adiponectin rising in two, and insulin sensitivity improving in six of ten. Its own authors describe the data as conflicting. Volume differs between studies, patients differ, and heavier people with more inflammatory fat may respond where lighter people do not. So my position is that liposuction is a contouring operation with a possible, unproven, volume-dependent metabolic dividend. I plan for the contour. Anything more is a welcome surprise.

  8. How do you plan liposuction around this biology?

    By treating regions in relationship rather than in isolation. I bring the flanks, hips and abdomen into a considered proportion, because the untreated zones are exactly where a future surplus will be stored. I also preserve a deliberate superficial layer of fat beneath the skin while removing the deeper stratum. This protects against contour irregularity and keeps the transitions smooth. So I am designing for a body at more than one weight. A silhouette that only works at the weight you hold today is a poorly designed silhouette.



GET APPOINTMENT

Get ready to look and feel best… You deserve…

Contact Dr. Nazmi Baycin's Dubai clinic for a private consultation
Click For Instant Contact or Send Message

    Go To Top
    About Dr. Nazmi Baycin

    Surgery, to me, is precision applied in service of restoration — a conviction that has guided every one of the more than 7,000 procedures I have performed over 25 years in practice. I am a DHA-licensed, board-certified plastic surgeon, trained in Turkey and based in Dubai since 2016. I operate exclusively within JCI-accredited hospitals, and hold international membership in the American Society of Plastic Surgeons (ASPS). Three techniques, in particular, have become signatures of my practice. Scarless breast augmentation, performed through a transaxillary approach that leaves no incision on the breast itself. Labiaplasty designed individually around each patient's own anatomy, never to a standard template. And 3D customised facial bone implants, engineered through CT-based bespoke printing — a technique I currently offer as the only surgeon in Dubai providing it. My practice today spans facial rejuvenation, breast surgery, body contouring, and cosmetic genital procedures, drawing patients from across the UAE, Europe, and the wider GCC. Yet the principle guiding each of these specialties has never changed: to restore form is to restore function. Read Dr. Baycin's full profile

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    error: Content is protected !!